Slideshow

Serious Infection in Systemic Lupus Erythematosus

Updates from the 2018 European Lupus Society Meeting focus on the risk infection poses to patients with SLE.

References1. Simard J, Rossides M, Arkema E. Serious infection rates in systemic lupus erythematosus: a Swedish population-based assessment. Presented at: 11th SLEuro European Lupus Society Meeting; March 21-24, 2018; Dusseldorf, Germany.2. Iglesias AL, Pego-Reigosa JM, López-Longo FJ, et al. Bacteremia in systemic lupus erythematosus patients from Relesser Registry: risk factors, clinical and microbiological characteristics and outcomes. Presented at: 11th SLEuro European Lupus Society Meeting; March 21-24, 2018; Dusseldorf, Germany.

Related Videos
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
© 2025 MJH Life Sciences

All rights reserved.